Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent energy metabolism is the fundamental biological process by which cells generate adenosine triphosphate (ATP) through pathways such as glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation [PMID: 29123077]. It is not a single molecular target but rather a complex network of enzymes and transporters that maintain cellular energy homeostasis. In diseases like cancer, cells often undergo metabolic reprogramming, such as the Warburg effect, to support rapid proliferation [PMID: 20305636]. Therapeutic strategies often target specific nodes within this metabolism, such as ATP synthase or AMP-activated protein kinase (AMPK), to treat metabolic disorders or selectively kill malignant cells [PMID: 30585048]. However, because these pathways are essential for the survival of all healthy cells, targeting them presents significant challenges regarding systemic toxicity and the therapeutic window [PMID: 27112567].
Modulation of ATP production through the inhibition or activation of specific enzymes and transporters within the glycolytic and mitochondrial respiratory chains [PMID: 30585048].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent energy metabolism.